Evidence map›Paper›PMID 42598416›Full record

ArticleACS omega2026

Stoichiometric MACl/PbCl

Vishal Viswakarman, Miguel García Rocha, Johann Bouclé

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vishal ViswakarmanCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Program on Nanoscience and Nanotechnology, Av. Instituto Politécnico Nacional, 2508, Col. San Pedro Zacatenco, Ciudad de México, Código Postal 07360, México.ORCID https://orcid.org/0009-0005-3749-5910
Miguel García RochaCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Program on Nanoscience and Nanotechnology, Av. Instituto Politécnico Nacional, 2508, Col. San Pedro Zacatenco, Ciudad de México, Código Postal 07360, México.ORCID https://orcid.org/0000-0001-8552-357X
Johann BoucléUniv. Limoges, CNRS, XLIM, UMR 7252, F-87000 Limoges, France.ORCID https://orcid.org/0000-0002-7851-1842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chloride-based additive engineering has become nearly indispensable in the development of high-efficiency perovskite solar cells (PSCs), with the majority of record-setting devices achieving power conversion efficiencies (PCE) exceeding 25% using methylammonium chloride (MACl) as a processing additive. However, the extreme process sensitivity and consequent irreproducibility associated with MACl incorporation are rarely addressed. Here, we systematically investigate MACl-processed FA

Identifiers

PMID42598416
PMCPMC13470813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.